Celldex to Report Second Quarter 2017 Financial Results and Host Corporate Update Call
03 August 2017 - 1:30AM
Celldex Therapeutics, Inc. (Nasdaq:CLDX) will release second
quarter 2017 financial results on Tuesday, August 8, 2017 after the
U.S. financial markets close. Celldex executives will host a
conference call at 4:30 p.m. EDT on the same day to review the
second quarter 2017 financial results and to provide an update on
key research and development and business objectives for the
remainder of 2017.
The conference call and presentation will be webcast live over
the Internet and can be accessed by going to the "Events &
Presentations" page under the "Investors & Media" section of
the Celldex Therapeutics website at www.celldex.com. The call can
also be accessed by dialing (866) 743-9666 (within the United
States) or (760) 298-5103 (outside the United States). The passcode
is 52336196.
A replay of the call will be available approximately two hours
after the live call concludes through August 15, 2017. To access
the replay, dial (855) 859-2056 (within the United States) or (404)
537-3406 (outside the United States). The passcode is 52336196. The
webcast will also be archived on the Company's website.
About Celldex Therapeutics, Inc.
Celldex is developing targeted therapeutics to address
devastating diseases for which available treatments are inadequate.
Our pipeline is built from a proprietary portfolio of antibodies
and immunomodulators used alone and in strategic combinations to
create novel, disease-specific therapies that induce, enhance or
suppress the body's immune response. Visit www.celldex.com.
Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs and Administration
Celldex Therapeutics, Inc.
(781) 433-3161
scavanaugh@celldex.com
Charles Liles
Associate Director, Investor Relations & Corp Communications
Celldex Therapeutics, Inc.
(617) 383-3433
cliles@celldex.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Apr 2024 to May 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From May 2023 to May 2024